Humanin peptides block calcium influx of rat hippocampal neurons by altering fibrogenesis of Aβ1-40

Peptides

Volumn 24, Issue 5, 2003, Pages 679-685

  Zou, Ping ^a   Ding, Yanan ^a   Sha, Yinlin ^a   Hu, Baihe ^a   Nie, Songqing ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

A aggregation; Calcium influx; Electron microscopy; Humanin; Neurotoxicity

Indexed keywords

CALCIUM ANTAGONIST; HUMANIN; NEUROPROTECTIVE AGENT; PEPTIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL CULTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FIBROGENESIS; HIPPOCAMPUS; LIGHT SCATTERING; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; STATISTICAL SIGNIFICANCE;

EID: 0043207393     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(03)00131-1     Document Type: Article

References (22)

1. Arispe N., Rojas E., Pollard H.B. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminium. Proc. Natl. Acad Sci. U.S.A. 90:1993;567-571.
2. Brewer G.J. Isolation and culture of adult rat hippocampal neurons. J. Neurosci. Methods. 71:1997;143-155.
3. Carrell R.W., Lomas D.A. Conformational disease. Lancet. 350:1997;134-138.
4. Fields G.B., Noble R.L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxy-carbonyl amino acids. Int. J. Pept. Protein Res. 35:1990;161-214.
5. Gearing M., Mori H., Mira S. Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann. Neurol. 39:1996;395-399.
6. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:1992;184-185.
7. Harper J.D., Lansbury P.T. Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66:1997;385-407.
8. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol. 4:1997;119-125.
9. Hashimoto Y., Ito Y., Niikura T., Shao Z.J., Hata M., Oyama F., Nishimoto I. Mechanism of neuroprotection by a novel resue factor humanin from Swedish mutant amyloid precursor protein. Biochem. Biophys. Res. Commun. 83:2001;460-468.
10. Hashimoto Y., Niikura T., Ito Y., Sudo H., Hata M., Arakawa E., Abe Y., Kita Y., Nishimoto I. Detailed characterization of neuroprotection by a resue factor humanin against various Alzheimer's disease-relevant insults. J. Neurosci. 21:2001;9235-9245.
11. Hashimoto Y., Niikura T., Tajima H., Yasukawa T., Sudo H., Ito Y., Kita Y., Kawasumi M., Kouyama K., Doyu M., Sobue G., Koidek T., Tsuji S., Lang J., Kurokawa K., Nishimoto I. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ Proc. Natl. Acad. Sci. U.S.A. 98:2001;6336-6341.
12. Kaneko I., Yamada N., Sakuraba Y., Kamenosono M., Tutumi S. Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue. J. Neurochem. 65:1995;2585-2593.
13. Katzman R, Kawas C. The epidemiology of dementia and Alzheimer disease. In: Terry RD, Katzman R, Bick KL, editors. Alzheimer disease. New York: Raven Press; 1994. p. 105.
14. Kawahara M., Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's β-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res. Bull. 4:2000;389-397.
15. Lomakin A., Chung D.S., Benedek G.B., Kirschner D.A., Teplow D.B. On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad Sci. U.S.A. 93:1996;1125-1129.
16. Lomakin A., Teplow D.B., Kirschner D.A., Benedek G.B. Kinetic theory of fibrillogenesis of amyloid β-protein. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7942-7947.
17. 1-40 on membrane fluidity and permeability. Protein Pept. Lett. 9:2002;173-178.
18. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
19. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
20. Seubert P., Oltersdorf T., Lee M.G., Barbour R., Blomquist C., Davis D.L.et al. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature. 361:1993;260-263.
21. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A.et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
22. Zagorski MG, Yang J, Shao H, Ma K, Zeng H, Hong A. Methodological and chemical factors affecting amyloid β peptide amyloidogenicity. In: Colowick SP, Kaplan NO, editors. Methods in enzymology, vol. 309. New York: Academic Press; 1999. p. 189-204.